Quantcast

Latest Lymphoma Stories

2014-12-12 08:26:10

SUNNYVALE, Calif., Dec.

2014-12-09 00:20:42

Follow-up data from the Phase 2 PCYC-1104 trial presented at the American Society of Hematology Annual Meeting show sustained efficacy and safety over time SAN FRANCISCO and RARITAN, N.J.,

2014-12-09 00:20:34

- Note: This press release corresponds to abstracts 4453 and 4471 SAN FRANCISCO, Dec.

2014-12-08 20:20:32

Data Show 84% Progression-Free Survival Rate at One Year and Improvement in Quality of Life SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- Pharmacyclics, Inc.

2014-12-08 20:20:20

- Note: This press release corresponds to abstracts 627 and 1998. SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- New IMBRUVICA(®) (ibrutinib) Phase II data announced by Pharmacyclics, Inc.

2014-12-06 16:21:17

- Note: This press release corresponds to abstract 31. SAN FRANCISCO, Dec. 6, 2014 /PRNewswire/ -- New IMBRUVICA(®) (ibrutinib) Phase II data announced here today by Pharmacyclics, Inc.

2014-12-06 12:21:53

Overall Response Rate of 66 Percent Observed in Pembrolizumab-treated Patients Whose Cancer Progressed on Brentuximab Vedotin Phase 2 Study Planned for the First Half of 2015

2014-12-05 12:25:02

- Updated results from pilot Phase II trial of the BCL2 targeting DNAi® therapeutic reported at ASH 2014 - VANCOUVER, BC and PLYMOUTH, MI, Dec.


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related